130 related articles for article (PubMed ID: 1600337)
1. Is soluble CD25 antigen (interleukin-2 receptor) a useful parameter for differential diagnosis of thyrotoxicosis?
Hüfner M; Wermann M; Grussendorf M; Heilig B
Clin Investig; 1992 Feb; 70(2):122-4. PubMed ID: 1600337
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
Izumi Y; Takeoka K; Amino N
Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
[TBL] [Abstract][Full Text] [Related]
3. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
[TBL] [Abstract][Full Text] [Related]
4. Marine-Lenhart syndrome.
Cakir M
J Natl Med Assoc; 2005 Jul; 97(7):1036-8. PubMed ID: 16080676
[TBL] [Abstract][Full Text] [Related]
5. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
Yoshimura Noh J; Momotani N; Fukada S; Ito K; Miyauchi A; Amino N
Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
[TBL] [Abstract][Full Text] [Related]
6. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
[TBL] [Abstract][Full Text] [Related]
7. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of postpartum thyrotoxicosis by serum thyroglobulin: usefulness of a new multisite immunoradiometric assay.
Hidaka Y; Nishi I; Tamaki H; Takeoka K; Tada H; Mitsuda N; Amino N
Thyroid; 1994; 4(3):275-8. PubMed ID: 7833663
[TBL] [Abstract][Full Text] [Related]
9. Increased soluble interleukin 2 receptor levels in autoimmune thyroid disease.
Nakanishi K; Taniguchi Y; Ohta Y
Acta Endocrinol (Copenh); 1991 Sep; 125(3):253-8. PubMed ID: 1683085
[TBL] [Abstract][Full Text] [Related]
10. [In vitro diagnosis of T3 thyrotoxicosis].
Semenov VD
Med Radiol (Mosk); 1983 Jun; 28(6):72-5. PubMed ID: 6688114
[TBL] [Abstract][Full Text] [Related]
11. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study.
Carlé A; Knudsen N; Pedersen IB; Perrild H; Ovesen L; Rasmussen LB; Laurberg P
Eur J Endocrinol; 2013 Nov; 169(5):537-45. PubMed ID: 23935127
[TBL] [Abstract][Full Text] [Related]
12. [Thyrotoxicosis].
Mattsson C; Hägg E
Lakartidningen; 2004 Oct; 101(42):3249-52. PubMed ID: 15544131
[No Abstract] [Full Text] [Related]
13. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to the thyroid gland and to the thyrotrophin receptor in African and Indian thyrotoxic patients.
Desai RK; Jialal I; Omar MA; Rajput MC; Joubert SM
Postgrad Med J; 1986 Sep; 62(731):837-9. PubMed ID: 3809073
[TBL] [Abstract][Full Text] [Related]
15. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy.
Hidaka Y; Tamaki H; Iwatani Y; Tada H; Mitsuda N; Amino N
Clin Endocrinol (Oxf); 1994 Jul; 41(1):15-20. PubMed ID: 7914152
[TBL] [Abstract][Full Text] [Related]
16. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
Yoshihara A; Noh JY; Mukasa K; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Watanabe N; Suzuki N; Kameda T; Sugino K; Ito K
Endocr J; 2015; 62(6):557-60. PubMed ID: 25819223
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
Ide A; Amino N; Kang S; Yoshioka W; Kudo T; Nishihara E; Ito M; Nakamura H; Miyauchi A
Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
[TBL] [Abstract][Full Text] [Related]
19. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
20. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
